Homocysteine in Athletes: What Your Blood Work Is Actually Telling You
Table of Contents
Introduction: Why Homocysteine in Athletes Deserves a Closer Look
Although homocysteine is not routinely tested in athletes, it can occasionally appear on a blood panel when the test is ordered for other clinical reasons — such as suspected B-vitamin deficiency, macrocytosis, anemia workup, renal issues, or cardiovascular risk assessment. And when homocysteine is measured in an athlete, the result may need more context than a standard reference range can provide. After a marathon, homocysteine — a marker associated with cardiovascular risk — can rise by 64% above pre-race levels [2]. At elevated resting concentrations, the same marker has been reported in nearly half of athletes in one competitive cohort, compared with 15% of healthy non-athletic controls [3].
Homocysteine (Hcy) is a sulfur-containing amino acid produced during the metabolism of methionine [6]. Under normal physiological conditions, homocysteine is cleared efficiently through two major pathways: remethylation back to methionine (requiring folate and vitamin B12) and transsulfuration to cysteine (requiring vitamin B6) [6]. When these metabolic pathways are affected by recent exercise [1], marginal B-vitamin status, renal function, or genetic factors, homocysteine may rise. And elevated homocysteine is not a benign bystander: each increase of 5 µmol/L in homocysteine level increases the risk of coronary heart disease (CHD) events by approximately 20%, independently of traditional CHD risk factors [5].
In my clinical experience, homocysteine is still a relatively unfamiliar marker for many clinicians outside specialist settings. More often, it is tested in hematology or internal medicine, especially when evaluating unexplained changes in the blood count, macrocytosis, anemia, or suspected deficiencies in folate, vitamin B12, or sometimes vitamin B6.
This distinction is important in athletes. Although we know from the research that homocysteine values can change — and in some settings rise — after exercise, homocysteine is not really an athlete-specific marker in routine clinical practice. In that sense, elevated homocysteine in athletes is often more of a scientific curiosity and a useful window into exercise physiology than a practical performance or monitoring marker.
In the clinic, I would not usually order homocysteine just to assess training adaptation, recovery, or athletic performance. For athletes, the key point is not that homocysteine should become a standard sports biomarker, but that if it is measured, it should be interpreted with awareness of recent exercise, nutritional status, and the clinical context.
In this article I will break down what the research says about homocysteine in athletes specifically — how exercise affects it acutely and chronically, why elevated values may be more common in some athlete cohorts than clinicians expect, how to interpret homocysteine values on a blood panel, and what interventions the evidence actually supports.
The Problem: Homocysteine in Athletes Is Not What Clinicians Expect
Several sports medicine studies challenge the assumption that homocysteine above 15 µmol/L is rare in healthy athletes [3][4] — and the same pattern holds across other markers where the athlete context redefines what “normal” means, as I’ve explored in ferritin levels for athletes and HbA1c in athletes.
A case-control study published in the British Journal of Sports Medicine enrolled 82 athletes (59 male, 23 female) practising different sports, alongside 70 healthy age-matched subjects as a control group. The prevalence of hyperhomocysteinaemia (>15 µmol/l) in athletes and controls was 47% and 15%, respectively [3]. Nearly half of competitive athletes already exceeded the clinical threshold — despite being apparently healthy, fit individuals with a low conventional cardiovascular risk profile.
A longitudinal study of elite winter sports athletes (103 athletes, 59 males and 44 females) found that the percentages of athletes with normal and elevated homocysteine levels, defined by levels below or above the limit of 15 µmol/l, were 68.0% and 32.0%, respectively, in the recovery period, and these percentages remained unchanged during the following periods. In the control group, relevant percentages were 92.9% and 7.1%, respectively [4]. Athletes had a 4.5-fold higher prevalence of hyperhomocysteinemia than controls, suggesting that elevated homocysteine was not limited to a single measurement period in this elite winter sports cohort.
The BJSM study also found that no correlation was found between homocysteine and any of the other investigated variables, in particular plasma folate, blood pressure, LDH, CPK, total and HDL cholesterol and IL-6 [3]. This means clinicians cannot simply explain elevated homocysteine in athletes by pointing to obvious dietary deficiencies, inflammation, or muscle damage markers. The authors suggested that this elevation “would represent an adaptation to training but the possibility of a secondary vascular damage cannot be excluded” [3].
It is also important to keep the clinical significance of homocysteine in perspective. In athletes, an elevated homocysteine value is usually not a risk factor in the same way it may be interpreted in patients with established cardiovascular disease or a high vascular risk profile. Most athletes, especially endurance-trained athletes, have a more favourable vascular and metabolic profile than sedentary populations, so the meaning of a mildly elevated homocysteine result is not automatically the same.
In practice, when I see elevated homocysteine in an athlete, I do not treat the number in isolation. I first think about B-vitamin status, especially folate and vitamin B12, and whether the result may reflect recent training, diet, renal function, or individual differences in homocysteine metabolism. If there is no clear deficiency, no renal issue, no relevant cardiovascular risk context, and no other abnormality in the blood panel, a mildly elevated homocysteine value alone does not usually lead to major clinical action.
This is also true in many non-athlete clinical situations. Homocysteine can support broader clinical reasoning, but it rarely makes decisions by itself. It is often best understood as a contextual marker: useful when it points toward B-vitamin deficiency, altered metabolism, renal impairment, or cardiovascular risk, but not something that should automatically trigger treatment simply because the number is above a reference threshold.
Why Exercise Drives Homocysteine in Athletes Upward: The Mechanism
Understanding why exercise elevates homocysteine in athletes requires a brief look at the metabolic pathways involved.
Homocysteine sits at the intersection of two critical cycles. It is produced every time the body uses S-adenosylmethionine (SAM) as a methyl donor. Under normal circumstances, Hcy is recycled back to methionine via the remethylation pathway, through the action of various enzymes and vitamins, particularly folic acid (vitamin B9) and B12. A second pathway — the transsulfuration pathway — recycles Hcy into cysteine, a precursor of glutathione, in a reaction requiring vitamin B6 [6].
Exercise appears to acutely increase flux through this system, although the exact mechanism remains incompletely established [1]. A PRISMA-compliant meta-analysis of 22 studies with 520 participants confirmed that acute exercise increases plasma homocysteine concentration by 1.18 µmol/L (95% CI: 0.71 to 1.65, p < .01) on average [1]. Both long-duration low-to-moderate intensity exercise (1.39 µmol/L, 95% CI: 0.90 to 1.89) and short high-intensity exercise (0.83 µmol/L, 95% CI: 0.19 to 1.40) drove homocysteine in athletes upward [1].
Two overlapping mechanisms have been proposed. First, increased protein catabolism during exercise may raise the pool of free amino acids, increasing flux through the methionine cycle and Hcy formation [1]. Second, exercise has been proposed to increase demand for several methylated compounds such as DNA, epinephrine, acetylcholine, carnitine, and creatine, which along with Hcy are products of transmethylation reactions [1]. Research has additionally suggested that acute variations in homocysteine levels are related to creatine changes induced by physical activity [7].
Longer, higher-volume sessions appear to be an important contributor to the acute Hcy response, which makes endurance exercise particularly relevant when interpreting recent training load [1]. This connects to the broader picture of how high training volumes affect multiple biomarkers simultaneously, as I also cover in the context of cortisol in athletes and the T:C ratio in overtraining.
However, this exercise-related mechanism should be separated from the more common clinical reasons for elevated homocysteine. In sports physiology, a temporary rise in homocysteine may reflect acute changes in methylation demand, amino acid turnover, training volume, or recent endurance exercise. In clinical medicine, elevated homocysteine is usually interpreted through a different lens: folate or vitamin B12 deficiency, macrocytosis, anemia workup, renal impairment, genetic variation in homocysteine metabolism, medication effects, or broader cardiovascular risk assessment.
How High Does Homocysteine in Athletes Go, and How Long Does It Stay Elevated?
Marathon running induced a Hcy increase of 64%, while mountain biking and 100 km running showed no statistically significant change in Hcy in this study [2]. In absolute terms, marathon runners who started with median pre-race Hcy of 9.8 (7.4–11.1) µmol/L reached median values of 16.1 (12.7–20.4) µmol/L at 15 minutes post-finish — exceeding the clinical hyperhomocysteinemia threshold acutely [2].
Furthermore, about 25% of recreational endurance athletes exhibited hyperhomocysteinemia in association with low vitamin B12 and folate levels [2]. In this study, athletes with pre-race Hcy >12 µmol/L had relatively lower folate (14.3 nmol/L) and vitamin B12 levels (231 pmol/L), suggesting that B-vitamin status may contribute to elevated pre-race Hcy in some endurance athletes [2].
The good news on acute elevations is that the increase in Hcy after acute exercise is transitory and liable to return to baseline levels in less than 24 h independent of exercise intensity [1]. However, the exact recovery kinetics depend on exercise volume — and the meta-analysis notes that the increase induced by acute exercise “may not be deemed a risk factor of cardiovascular events mediated by hyperhomocysteinemia” at these magnitudes [1].
On a chronic basis, resistance training reduced plasma Hcy concentration by −1.53 µmol/L (95% CI: −2.77 to −0.28, p = .02), though aerobic training did not produce a significant reduction (0.19 µmol/L, 95% CI: −0.67 to 1.06, p = .66) [1]. This counterintuitive finding — that the exercise modality most commonly prescribed for cardiovascular health does not lower resting homocysteine in athletes — is clinically interesting, although it should be interpreted cautiously: the exercise training analysis in the meta-analysis was based on only seven studies [1]. It parallels the well-documented patterns with creatine kinase elevated in athletes and myoglobin in athletes, where the same training that builds fitness also stresses multiple biomarker systems.
Clinically, it is important to remember that an isolated, exercise-related rise in homocysteine does not automatically carry clinical significance in athletes. If the elevation is temporary, clearly related to recent endurance exercise, and other relevant causes have been excluded — such as folate or vitamin B12 deficiency, renal impairment, macrocytosis, anemia, or broader cardiovascular risk factors — I would not interpret that result as an independent cardiovascular risk signal.
In practical terms, if an athlete has a mildly elevated homocysteine value but the rest of the clinical picture is reassuring, I do not treat the number itself. I would first check why the test was ordered, when the blood sample was taken in relation to training, and whether there is any evidence of B-vitamin deficiency or another underlying condition. If those explanations are ruled out, an isolated exercise-associated elevation would not usually be a cause for concern in my clinical practice.
This is also why homocysteine should not be ordered routinely in athletes just because they train hard. In my view, the test is most useful when there is a real clinical reason to look for it — for example suspected folate or vitamin B12 deficiency, unexplained macrocytosis, anemia workup, renal disease, or a broader cardiovascular risk assessment. Without that context, homocysteine can easily become a number that creates more confusion than useful clinical information.
Conclusion: Homocysteine in Athletes
Homocysteine in athletes is a useful example of why blood test interpretation should never happen in isolation. On paper, homocysteine looks like a cardiovascular risk marker, and in many clinical contexts it can be relevant to vascular risk, renal function, folate status, vitamin B12 status, macrocytosis, anemia workup, and broader metabolic health. But athletes are not always best understood through the same lens as sedentary or high-risk cardiovascular populations. Training load, recent endurance exercise, nutritional status, renal handling, and individual differences in homocysteine metabolism can all change what the result actually means.
The research shows that homocysteine can rise acutely after exercise, especially after prolonged endurance events such as a marathon. It also suggests that elevated resting values may be more common in some athlete cohorts than many clinicians would expect. At the same time, this does not mean that homocysteine should become a routine sports performance marker, or that every mild elevation in an athlete should trigger concern. In my clinical practice, I would not order homocysteine simply to assess training adaptation, recovery, or performance. Its value is more specific: it becomes useful when there is a real clinical reason to look for it, such as suspected folate or vitamin B12 deficiency, unexplained changes in the blood count, renal impairment, or cardiovascular risk assessment.
For athletes, the key is context. A mildly elevated homocysteine result drawn soon after a hard training session or endurance event is not the same finding as persistent hyperhomocysteinemia in a patient with macrocytic anemia, renal disease, or established vascular risk. If an athlete has an isolated elevation but normal B-vitamin status, reassuring renal function, no relevant cardiovascular risk factors, and an otherwise unremarkable blood panel, the result may not require any major clinical action. It should first be interpreted by asking why the test was ordered, when the sample was taken, what the athlete’s recent training load looked like, and whether there are any other clinical clues pointing toward deficiency or disease.
This is the main message of homocysteine in athletes: the number itself is rarely the whole story. Homocysteine can be a helpful contextual marker, but it should not be treated as a standalone diagnosis or a direct measure of athletic health. When interpreted carefully, it may point toward B-vitamin status, altered metabolism, renal function, or recent exercise physiology. When interpreted without context, it can easily become a misleading abnormality that creates more anxiety than useful clinical information. For clinicians and athletes, the goal is not to chase the lowest possible homocysteine value, but to understand whether the result fits the broader clinical picture — and whether it actually changes anything meaningful in care.
Bibliography
[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC4795785/
[2] https://pubmed.ncbi.nlm.nih.gov/14656035/
[3] https://pubmed.ncbi.nlm.nih.gov/18216160/
[4] https://pubmed.ncbi.nlm.nih.gov/17598967/
[5] https://pubmed.ncbi.nlm.nih.gov/18990318/
